| A novel orvinol analog, BU08028, as a safe opioid analgesic without abuse liability in primates H Ding, PW Czoty, N Kiguchi, G Cami-Kobeci, DD Sukhtankar, MA Nader, ... Proceedings of the National Academy of Sciences 113 (37), E5511-E5518, 2016 | 105 | 2016 |
| Physiological function of gastrin-releasing peptide and neuromedin B receptors in regulating itch scratching behavior in the spinal cord of mice DD Sukhtankar, MC Ko PloS one 8 (6), e67422, 2013 | 59 | 2013 |
| Effects of spinally administered bifunctional nociceptin/orphanin FQ peptide receptor/μ-opioid receptor ligands in mouse models of neuropathic and inflammatory pain DD Sukhtankar, NT Zaveri, SM Husbands, MC Ko Journal of Pharmacology and Experimental Therapeutics 346 (1), 11-22, 2013 | 57 | 2013 |
| Supraspinal actions of nociceptin/orphanin FQ, morphine and substance P in regulating pain and itch in non‐human primates H Ding, K Hayashida, T Suto, DD Sukhtankar, M Kimura, V Mendenhall, ... British journal of pharmacology 172 (13), 3302-3312, 2015 | 54 | 2015 |
| BU10038 as a safe opioid analgesic with fewer side-effects after systemic and intrathecal administration in primates N Kiguchi, H Ding, G Cami-Kobeci, DD Sukhtankar, PW Czoty, HB DeLoid, ... British journal of anaesthesia 122 (6), e146-e156, 2019 | 45 | 2019 |
| Inhibition of p38-MAPK signaling pathway attenuates breast cancer induced bone pain and disease progression in a murine model of cancer-induced bone pain D Sukhtankar, A Okun, A Chandramouli, MA Nelson, TW Vanderah, ... Molecular pain 7, 1744-8069-7-81, 2011 | 45 | 2011 |
| Behavioral and neurochemical analysis of ongoing bone cancer pain in rats B Remeniuk, D Sukhtankar, A Okun, E Navratilova, JY Xie, T King, ... Pain 156 (10), 1864-1873, 2015 | 41 | 2015 |
| Differential effects of opioid-related ligands and NSAIDs in nonhuman primate models of acute and inflammatory pain DD Sukhtankar, H Lee, KC Rice, MC Ko Psychopharmacology 231, 1377-1387, 2014 | 36 | 2014 |
| Spinal functions of B-type natriuretic peptide, gastrin-releasing peptide, and their cognate receptors for regulating itch in mice N Kiguchi, DD Sukhtankar, H Ding, K Tanaka, S Kishioka, CM Peters, ... Journal of Pharmacology and Experimental Therapeutics 356 (3), 596-603, 2016 | 34 | 2016 |
| Disease modifying actions of interleukin-6 blockade in a rat model of bone cancer pain B Remeniuk, T King, D Sukhtankar, A Nippert, N Li, F Li, K Cheng, ... Pain 159 (4), 684-698, 2018 | 32 | 2018 |
| Effects of the NOP agonist SCH221510 on producing and attenuating reinforcing effects as measured by drug self-administration in rats DD Sukhtankar, CH Lagorio, MC Ko European journal of pharmacology 745, 182-189, 2014 | 30 | 2014 |
| Spinal antinociceptive effects of the novel NOP receptor agonist PWT2‐nociceptin/orphanin FQ in mice and monkeys A Rizzi, DD Sukhtankar, H Ding, K Hayashida, C Ruzza, R Guerrini, ... British journal of pharmacology 172 (14), 3661-3670, 2015 | 27 | 2015 |
| Mediation of movement-induced breakthrough cancer pain by IB4-binding nociceptors in rats J Havelin, I Imbert, D Sukhtankar, B Remeniuk, I Pelletier, J Gentry, ... Journal of Neuroscience 37 (20), 5111-5122, 2017 | 17 | 2017 |
| Pharmacological investigation of NOP-related ligands as analgesics without abuse liability D Sukhtankar, MC Ko Research and Development of Opioid-Related Ligands, 393-416, 2013 | 6 | 2013 |
| Pharmacokinetics and Pharmacodynamics of Burixafor Hydrobromide (GPC‐100), a Novel C‐X‐C Chemokine Receptor 4 Antagonist and Mobilizer of Hematopoietic Stem/Progenitor Cells … DD Sukhtankar, L Chang, C Tsai, PM Cardarelli, NG Caculitan Clinical Pharmacology in Drug Development 12 (11), 1114-1120, 2023 | 3 | 2023 |
| GPC-100, a novel CXCR4 antagonist, improves in vivo hematopoietic cell mobilization when combined with propranolol DD Sukhtankar, JJ Fung, M Kim, T Cayton, V Chiou, NG Caculitan, ... Plos one 18 (10), e0287863, 2023 | 3 | 2023 |
| Effects of spinally administered bifunctional NOP/MOP ligands in mouse models of neuropathic and inflammatory pain DD Sukhtankar, NT Zaveri, SM Husbands, MC Ko Journal of Pharmacology and Experimental Therapeutics, 2013 | 2 | 2013 |
| GPC-100 is a novel CXCR4 inhibitor that leads to improved in vitro potency and in vivo efficacy in stem cell mobilization when combined with a beta-blocker JJ Fung, V Chiou, J Lee, Y Jang, J Choi, P Zalicki, T Cayton, A Chin, ... Blood 140 (Supplement 1), 4489-4490, 2022 | 1 | 2022 |
| (306) Pain and pain relief: using motivation to explore mechanisms underlying cancer-induced pain in rats M Dearborn, I Pelletier, J Gentry, J Havelin, I Imbert, D Sukhtankar, ... The Journal of Pain 17 (4), S52, 2016 | 1 | 2016 |
| Supraspinal actions of N/OFQ, morphine and substance P in regulating pain and itch in nonhuman primates H Ding, K Hayashida, T Suto, D Sukhtankar, M Kimura, V Mendenhall, ... The FASEB Journal 29, 929.5, 2015 | 1 | 2015 |
